ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 227 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,535,658 | +5.3% | 4,074,251 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $50,828,463 | -1.7% | 4,034,005 | +1.8% | 0.00% | 0.0% |
Q1 2023 | $51,711,134 | -62.3% | 3,962,539 | -49.1% | 0.00% | -25.0% |
Q4 2022 | $137,222,266 | +116.7% | 7,779,040 | +87.1% | 0.00% | 0.0% |
Q3 2022 | $63,314,000 | +0.4% | 4,157,188 | -2.3% | 0.00% | 0.0% |
Q2 2022 | $63,087,000 | -37.0% | 4,254,026 | -4.4% | 0.00% | -20.0% |
Q1 2022 | $100,174,000 | +25.9% | 4,448,241 | +3.2% | 0.01% | +25.0% |
Q4 2021 | $79,544,000 | +46.2% | 4,311,336 | +6.0% | 0.00% | +33.3% |
Q3 2021 | $54,396,000 | -33.2% | 4,068,512 | -7.5% | 0.00% | -25.0% |
Q2 2021 | $81,409,000 | +19.2% | 4,398,130 | -3.3% | 0.00% | 0.0% |
Q1 2021 | $68,300,000 | -4.7% | 4,548,792 | -8.4% | 0.00% | 0.0% |
Q4 2020 | $71,671,000 | +60.4% | 4,963,391 | -9.6% | 0.00% | +33.3% |
Q3 2020 | $44,687,000 | +16.3% | 5,489,843 | -3.3% | 0.00% | 0.0% |
Q2 2020 | $38,418,000 | -0.2% | 5,674,708 | +3.8% | 0.00% | 0.0% |
Q1 2020 | $38,498,000 | -24.4% | 5,468,496 | +5.3% | 0.00% | 0.0% |
Q4 2019 | $50,954,000 | -13.8% | 5,191,424 | -3.5% | 0.00% | -25.0% |
Q3 2019 | $59,085,000 | -8.1% | 5,381,152 | -2.7% | 0.00% | -20.0% |
Q2 2019 | $64,298,000 | +23.8% | 5,528,643 | +1.6% | 0.01% | +25.0% |
Q1 2019 | $51,936,000 | +2.1% | 5,444,073 | +3.2% | 0.00% | -20.0% |
Q4 2018 | $50,857,000 | -38.1% | 5,275,658 | -8.5% | 0.01% | -16.7% |
Q3 2018 | $82,192,000 | +20.6% | 5,767,834 | +1.6% | 0.01% | 0.0% |
Q2 2018 | $68,147,000 | -7.9% | 5,679,308 | -5.2% | 0.01% | 0.0% |
Q1 2018 | $74,017,000 | -16.7% | 5,993,485 | -1.9% | 0.01% | -14.3% |
Q4 2017 | $88,865,000 | +4.9% | 6,107,211 | +2.5% | 0.01% | 0.0% |
Q3 2017 | $84,749,000 | +11.1% | 5,955,817 | -0.3% | 0.01% | 0.0% |
Q2 2017 | $76,251,000 | +29.5% | 5,975,551 | +28.6% | 0.01% | +40.0% |
Q1 2017 | $58,902,000 | +22.4% | 4,644,830 | -1.5% | 0.01% | 0.0% |
Q4 2016 | $48,133,000 | -23.5% | 4,714,595 | -1.4% | 0.01% | -16.7% |
Q3 2016 | $62,948,000 | +3.2% | 4,779,487 | -0.5% | 0.01% | -14.3% |
Q2 2016 | $61,017,000 | -6.4% | 4,804,198 | -2.7% | 0.01% | 0.0% |
Q1 2016 | $65,205,000 | -13.1% | 4,936,217 | +1.2% | 0.01% | -12.5% |
Q4 2015 | $75,044,000 | +25.1% | 4,879,286 | +0.8% | 0.01% | +14.3% |
Q3 2015 | $60,008,000 | -7.0% | 4,839,585 | +2.6% | 0.01% | 0.0% |
Q2 2015 | $64,550,000 | +11.0% | 4,718,497 | -3.0% | 0.01% | +16.7% |
Q1 2015 | $58,174,000 | -5.4% | 4,863,963 | +1.0% | 0.01% | 0.0% |
Q4 2014 | $61,516,000 | -4.5% | 4,817,391 | +0.3% | 0.01% | -14.3% |
Q3 2014 | $64,402,000 | -13.3% | 4,800,938 | +3.7% | 0.01% | -12.5% |
Q2 2014 | $74,317,000 | -9.7% | 4,630,443 | +1.4% | 0.01% | -11.1% |
Q1 2014 | $82,339,000 | -26.9% | 4,566,839 | -49.5% | 0.01% | +28.6% |
Q4 2013 | $112,665,000 | +62.0% | 9,052,131 | +93.6% | 0.01% | -22.2% |
Q3 2013 | $69,545,000 | +22.6% | 4,676,664 | +6.7% | 0.01% | +28.6% |
Q2 2013 | $56,715,000 | – | 4,383,089 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |